Evidence – Understanding Which Models Best Predict Systemic Responses to Intratumoral Immunotherapies
3:40 pm - Wednesday 2nd December 2026
- Exploring the limitations of traditional tumour models when evaluating immunemediated mechanisms of action
- Assessing how models can capture tumour antigen release, immune priming, and responses beyond the treated tumour site
- Applying translational learnings from intratumoral immunotherapy development to improve combination strategies and clinical translation
